bioMérieux BMXMF Stock
bioMérieux Price Chart
bioMérieux BMXMF Financial and Trading Overview
| bioMérieux stock price | 130.75 USD |
| Previous Close | 98.7 USD |
| Open | 98.16 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 98.7 - 98.7 USD |
| 52 Week Range | 78.06 - 110.14 USD |
| Volume | 24 USD |
| Avg. Volume | 50 USD |
| Market Cap | 11.64B USD |
| Beta (5Y Monthly) | 0.149425 |
| PE Ratio (TTM) | 23.95631 |
| EPS (TTM) | 4.12 USD |
| Forward Dividend & Yield | 0.91 (0.91%) |
| Ex-Dividend Date | June 6, 2023 |
| 1y Target Est | N/A |
BMXMF Valuation Measures
| Enterprise Value | 11.63B USD |
| Trailing P/E | 23.95631 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.2435067 |
| Price/Book (mrq) | 3.2314038 |
| Enterprise Value/Revenue | 3.24 |
| Enterprise Value/EBITDA | 14.288 |
Trading Information
bioMérieux Stock Price History
| Beta (5Y Monthly) | 0.149425 |
| 52-Week Change | 16.11% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 110.14 USD |
| 52 Week Low | 78.06 USD |
| 50-Day Moving Average | 104.32 USD |
| 200-Day Moving Average | 98.64 USD |
BMXMF Share Statistics
| Avg. Volume (3 month) | 50 USD |
| Avg. Daily Volume (10-Days) | 100 USD |
| Shares Outstanding | 117.95M |
| Float | 42.68M |
| Short Ratio | N/A |
| % Held by Insiders | 64.28% |
| % Held by Institutions | 19.05% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.85 |
| Trailing Annual Dividend Yield | 0.86% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.2225 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 12.60% |
| Operating Margin (ttm) | 17.07% |
| Gross Margin | 55.96% |
| EBITDA Margin | 22.68% |
Management Effectiveness
| Return on Assets (ttm) | 7.82% |
| Return on Equity (ttm) | 12.94% |
Income Statement
| Revenue (ttm) | 3.59B USD |
| Revenue Per Share (ttm) | 30.43 USD |
| Quarterly Revenue Growth (yoy) | 7.19% |
| Gross Profit (ttm) | 2.01B USD |
| EBITDA | 814M USD |
| Net Income Avi to Common (ttm) | 452.4M USD |
| Diluted EPS (ttm) | 4.12 |
| Quarterly Earnings Growth (yoy) | -30.69% |
Balance Sheet
| Total Cash (mrq) | 552.6M USD |
| Total Cash Per Share (mrq) | 4.69 USD |
| Total Debt (mrq) | 505.4M USD |
| Total Debt/Equity (mrq) | 13.87 USD |
| Current Ratio (mrq) | 1.96 |
| Book Value Per Share (mrq) | 30.544 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 475.1M USD |
| Levered Free Cash Flow (ttm) | 167.76M USD |
Profile of bioMérieux
| Country | United States |
| State | N/A |
| City | Marcy l'Étoile |
| Address | 376 Chemin De l’Orme |
| ZIP | 69280 |
| Phone | 33 4 78 87 20 00 |
| Website | https://www.biomerieux.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 12557 |
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Q&A For bioMérieux Stock
What is a current BMXMF stock price?
bioMérieux BMXMF stock price today per share is 130.75 USD.
How to purchase bioMérieux stock?
You can buy BMXMF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for bioMérieux?
The stock symbol or ticker of bioMérieux is BMXMF.
Which industry does the bioMérieux company belong to?
The bioMérieux industry is Diagnostics & Research.
How many shares does bioMérieux have in circulation?
The max supply of bioMérieux shares is 117.93M.
What is bioMérieux Price to Earnings Ratio (PE Ratio)?
bioMérieux PE Ratio is 31.73543700 now.
What was bioMérieux earnings per share over the trailing 12 months (TTM)?
bioMérieux EPS is 4.12 USD over the trailing 12 months.
Which sector does the bioMérieux company belong to?
The bioMérieux sector is Healthcare.